Current approaches aiming at overcoming resistance of tumors in this subset of patients include combining different ICIs with either chemotherapy, VEGF inhibitors, cancer vaccines, adoptive cell transfer, or BTC antibodies. The gene discussed is VEGFA; the disease is cancer.